Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Preclinical and clinical evaluation of LY3451838, a PACAP-neutralizing monoclonal antibody, in randomized, double-blind, placebo-controlled phase 1 and phase 2 studies involving healthy adults and adults with treatment-resistant migraine.
Journal: Cephalalgia : an international journal of headache
Published: August 21, 2025
Binding, Neutralization and Internalization of the Interleukin-13 Antibody, Lebrikizumab.
Journal: Dermatology and therapy
Published: April 03, 2023
Investigation of Immune Responses to Oxidation, Deamidation, And Isomerization in Therapeutic Antibodies using Preclinical Immunogenicity Risk Assessment Assays.
Journal: Journal of pharmaceutical sciences
Published: January 10, 2022
Generation and Characterization of Torudokimab (LY3375880): A Monoclonal Antibody That Neutralizes Interleukin-33.
Journal: Journal of inflammation research
Published: May 20, 2021
Cell culture media impact on drug product solution stability.
Journal: Biotechnology progress
Published: January 22, 2016
N+1 Engineering of an Aspartate Isomerization Hotspot in the Complementarity-Determining Region of a Monoclonal Antibody.
Journal: Journal of pharmaceutical sciences
Published: July 21, 2015
IL-33 released by alum is responsible for early cytokine production and has adjuvant properties.
Journal: Scientific reports
Published: March 20, 2015
Showing 1-7 of 7
Last Updated: 09/26/2026